CGEN Q4 2022 Earnings — Compugen Ltd. Revenue & Financial Results | Market Cap Arena

CGENCompugen Ltd.

$202M

Q4 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$8M

Gross Profit

$7M87.0% margin

Operating Income

-$4M-47.1% margin

Net Income

-$3M-41.2% margin

EPS (Diluted)

$-0.04

QoQ Revenue Growth

+Infinity%

Cash Flow

Operating Cash Flow

-$23M

Free Cash Flow

-$23M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$94M

Total Liabilities

$16M

Stockholders' Equity

$78M

Cash & Equivalents

$11M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$8M	$0	—
Gross Profit	$7M	$0	—
Operating Income	-$4M	-$9M	+59.8%
Net Income	-$3M	-$9M	+64.2%